Form 4 for ANIX Anixa Biosciences Inc
Accepted 2026-07-16 09:00:10 ET · period of report 2026-07-15 · accession 0001493152-26-033461 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-16 09:00 | 2026-07-15 | ANIX | Titterton Lewis H jr | Dir | P - Purchase | $3.28 | +2,797 | 975.0K | +0.3% | +$9,174 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-15 | P | A | 2,797 | $3.28 | 974,967 | D | — | — |